Apple Inc. litigation

Motorola Solutions' Patent Infringement Lawsuit Against Hytera Communications Will Proceed, Including Claims Against Hytera’s i-Series Product Line

Retrieved on: 
Tuesday, August 20, 2019

The Illinois District Court patent infringement lawsuit asserts that Hyteras two-way radios, base stations, repeaters and dispatch systems are infringing seven patents owned by Motorola Solutions and that Hyteras redesigned i-Series products are infringing four of those patents.

Key Points: 
  • The Illinois District Court patent infringement lawsuit asserts that Hyteras two-way radios, base stations, repeaters and dispatch systems are infringing seven patents owned by Motorola Solutions and that Hyteras redesigned i-Series products are infringing four of those patents.
  • Most recently, in May 2019, the U.S. Patent and Trademark Office upheld the validity of Motorola Solutions U.S. Patent Nos.
  • Collectively, Motorola Solutions patents at the center of the Illinois District Court patent infringement case enable important functionality to ensure reliable, high-quality communications.
  • MOTOROLA, MOTOROLA SOLUTIONS and the Stylized M Logo are trademarks or registered trademarks of Motorola Trademark Holdings, LLC and are used under license.

Court of Appeals Rules for Oracle Affirming Injunction against Rimini Street

Retrieved on: 
Monday, August 19, 2019

REDWOOD SHORES, Calif., Aug. 19, 2019 /PRNewswire/ -- The Ninth Circuit Court of Appeals has rejected Rimini Street's latest attempt to avoid the District Court's injunction barring Rimini Street from engaging in conduct that infringes Oracle's intellectual property rights.

Key Points: 
  • REDWOOD SHORES, Calif., Aug. 19, 2019 /PRNewswire/ -- The Ninth Circuit Court of Appeals has rejected Rimini Street's latest attempt to avoid the District Court's injunction barring Rimini Street from engaging in conduct that infringes Oracle's intellectual property rights.
  • The Appeals Court also affirmed the trial court's $28.5 million attorneys' fees award to Oracle, rejecting Rimini's absurd claim that it had prevailed at a trial where the jury found Rimini infringed Oracle's copyrights.
  • Rimini Street has paid more than $90 million to Oracle as a result of that infringement, and the trial court issued a permanent injunction.
  • "We are extremely gratified that the Ninth Circuit affirmed the permanent injunction and attorneys' fees award.

VirnetX Wins at Appeals Court as Apple's Request for En Banc is Denied

Retrieved on: 
Thursday, August 1, 2019

2018-1197, in which the court of appeals previously affirmed the judgement issued by the U.S. District Court for the Eastern District of Texas in favor of VirnetX in its litigation against Apple.

Key Points: 
  • 2018-1197, in which the court of appeals previously affirmed the judgement issued by the U.S. District Court for the Eastern District of Texas in favor of VirnetX in its litigation against Apple.
  • The district court judgement awarded VirnetX a total of $439.8 million, including damages for willful infringement and attorney fees.
  • Furthermore, we believe that Apple clearly and willfully infringed the claims upheld by the Federal Court."
  • VirnetX Holding Corporation is an Internet security software and technology company with patented technology for secure communications including 4G LTE and 5G security.

Illumina Wins Infringement Suit Against Ariosa Diagnostics, Inc.

Retrieved on: 
Monday, June 17, 2019

Illumina, Inc. (NASDAQ: ILMN) announced today that the High Court of Justice, Chancery Division, Patents Court in the United Kingdom issued a judgment in its favor in the patent infringement suit filed against Ariosa Diagnostics, Inc.

Key Points: 
  • Illumina, Inc. (NASDAQ: ILMN) announced today that the High Court of Justice, Chancery Division, Patents Court in the United Kingdom issued a judgment in its favor in the patent infringement suit filed against Ariosa Diagnostics, Inc.
  • The Court found that Ariosas Harmony non-invasive prenatal test infringed EP 1 524 321 and that the patent claims were valid.
  • The patent is directed to the size selection of extracellular DNA in maternal plasma samples.
  • Illumina intends to seek all available remedies for the infringement, including damages, injunctive relief, and attorney fees.

W.H.P.M. Inc. and Healgen Scientific Agree to Preliminary Injunction in Patent Infringement Lawsuit

Retrieved on: 
Thursday, May 30, 2019

("W.H.P.M.

Key Points: 
  • ("W.H.P.M.
  • "), a leading developer and manufacturer of rapid drugs of abuse and medical diagnostics devices, announced today that the company and Healgen Scientific LLC ("Healgen") have agreed to a preliminary injunction in a patent infringement lawsuit brought by W.H.P.M.
  • The lawsuit, filed in the U.S. District Court for the Southern District of Texas (Case 4:18-cv-02302), Houston Division alleged infringement of U.S. Patent No.
  • 7,927,562 (the " '562 Patent"), entitled "Collection and Assay Device for Biological Fluid", namely, the following Healgen devices SWABSCREEN devices manufactured, distributed, sold or offered for sale under any other name or label:

Exegy Files Patent Infringement Lawsuit Against ACTIV Financial

Retrieved on: 
Thursday, May 30, 2019

ST. LOUIS, May 30,2019 /PRNewswire/ -- Exegy Inc ., the leading provider of managed services and low-latency technology for market data normalization and distribution, today announced that it has filed a patent infringement lawsuit in the United States District Court for the Northern District of Illinois against ACTIV Financial Systems Inc. (ACTIV), a global distributor of financial market data.

Key Points: 
  • ST. LOUIS, May 30,2019 /PRNewswire/ -- Exegy Inc ., the leading provider of managed services and low-latency technology for market data normalization and distribution, today announced that it has filed a patent infringement lawsuit in the United States District Court for the Northern District of Illinois against ACTIV Financial Systems Inc. (ACTIV), a global distributor of financial market data.
  • Seeking monetary damages, an injunction, and destruction of all infringing products, the lawsuit asserts that ACTIV products infringe one or more claims in seventeen Exegy patents.
  • As a global leader in financial market data and low-latency technology, Exegy has patent rights in over 110 granted patents and over 30 pending patent applications worldwide, and other extensive intellectual property covering high-performance data processing technology.
  • Exegy provides low-latency market data normalization and distribution, market connectivity and price aggregation, and real-time trading signals to elite firms in the financial services industry.

Exegy Files Patent Infringement Lawsuit Against ACTIV Financial

Retrieved on: 
Thursday, May 30, 2019

ST. LOUIS, May 30,2019 /PRNewswire/ -- Exegy Inc ., the leading provider of managed services and low-latency technology for market data normalization and distribution, today announced that it has filed a patent infringement lawsuit in the United States District Court for the Northern District of Illinois against ACTIV Financial Systems Inc. (ACTIV), a global distributor of financial market data.

Key Points: 
  • ST. LOUIS, May 30,2019 /PRNewswire/ -- Exegy Inc ., the leading provider of managed services and low-latency technology for market data normalization and distribution, today announced that it has filed a patent infringement lawsuit in the United States District Court for the Northern District of Illinois against ACTIV Financial Systems Inc. (ACTIV), a global distributor of financial market data.
  • Seeking monetary damages, an injunction, and destruction of all infringing products, the lawsuit asserts that ACTIV products infringe one or more claims in seventeen Exegy patents.
  • As a global leader in financial market data and low-latency technology, Exegy has patent rights in over 110 granted patents and over 30 pending patent applications worldwide, and other extensive intellectual property covering high-performance data processing technology.
  • Exegy provides low-latency market data normalization and distribution, market connectivity and price aggregation, and real-time trading signals to elite firms in the financial services industry.

The HydraFacial Company Announces Judgement of Willful Patent Infringement Against Image Microderm

Retrieved on: 
Wednesday, May 29, 2019

LONG BEACH, Calif., May 29, 2019 /PRNewswire/ -- Edge Systems LLC DBA The HydraFacial Company filed a federal lawsuit against Image Microderm alleging that Image Microderm's BioXFusion MD and BioXFusion Mini products ("accused products") infringe several patents owned by The HydraFacial Company.

Key Points: 
  • LONG BEACH, Calif., May 29, 2019 /PRNewswire/ -- Edge Systems LLC DBA The HydraFacial Company filed a federal lawsuit against Image Microderm alleging that Image Microderm's BioXFusion MD and BioXFusion Mini products ("accused products") infringe several patents owned by The HydraFacial Company.
  • After aggressively enforcing its patent rights and defeating Image Microderm's baseless claims that The HydraFacial Company had somehow authorized Image Microderm's infringing acts, Image Microderm admitted that it had willfully infringed The HydraFacial Company's patent rights.
  • The Court granted the parties' consent judgment, decreeing that Image Microderm had willfully infringed The HydraFacial Company's patent rights and Ordering a permanent injunction against Image Microderm, which immediately stops Image Microderm from manufacturing or selling the accused products.
  • Since 1997, The HydraFacial Company has been a leading aesthetic device manufacturer, pioneering hydradermabrasion with both HydraFacial and Perk products.

Max Interactive, Inc. Response to Patent Infringement Lawsuit

Retrieved on: 
Thursday, May 2, 2019

COSTA MESA, Calif., May 02, 2019 /PRNewswire-PRWeb/ --Max Interactive, Inc., a leading manufacturer of protective cases and accessories, today responded to a patent infringement lawsuit: case number 8:19-cv-00608, filed in the U.S. District Court for the Central District of California.

Key Points: 
  • COSTA MESA, Calif., May 02, 2019 /PRNewswire-PRWeb/ --Max Interactive, Inc., a leading manufacturer of protective cases and accessories, today responded to a patent infringement lawsuit: case number 8:19-cv-00608, filed in the U.S. District Court for the Central District of California.
  • "On April 1, 2019, Max Interactive, Inc. (d/b/a/ MAXCases) was sued for patent infringement in the U.S. District Court for the Central District of California by TechShell, Inc. (TechShell) alleging that its Max Extreme Shell laptop cases infringe a family of patents owned by TechShell that related to protective covers for laptop computers.
  • Investigation of the TechShell patents indicates they do not cover any of MAXCases products.
  • MAXCases believes this lawsuit was brought without merit and it intends to vigorously defend against the baseless allegations of patent infringement.

Hi-Tech Pharmaceuticals Wins Almost $1 Million in Legal Fees From Thermolife and Stanford After Federal Circuit Affirms Major Patent Case

Retrieved on: 
Thursday, May 2, 2019

Beginning in March 2013, Thermolife filed eighty-one related patent infringement lawsuits in this Court, including the instant case regarding Hi-Tech Pharmaceuticals.

Key Points: 
  • Beginning in March 2013, Thermolife filed eighty-one related patent infringement lawsuits in this Court, including the instant case regarding Hi-Tech Pharmaceuticals.
  • 285, the court "in exceptional cases may award reasonable attorneys' fees to the prevailing party" in a patent infringement lawsuit.
  • In 2013 alone Thermolife and Kramer filed (117) patent infringement cases and (66) of those patents were licensed from Stanford University.
  • We insisted on seeking a return of our legal fees from Thermolife and Kramer and won a major victory at the Federal Circuit.